IL33 and neoplasm: Analysis of Siglec-F+PKH26+ cells over the total of PKH26+ tumor cells revealed that IL-33 EO formed increased numbers of cell conjugates with tumor cells, as compared to IL-5 EO (Figure 3A,B).